In line with its growth strategy, ALGAIA signed a distribution agreement with UNIPEX end December 2017. As of 1st January 2018, the agreement applies to the commercialization of all ALGAIA seaweed-based texturizing specialties aiming at cosmetic and industrial applications as well as the medical device industry. Its geographical scope involves France, Benelux, Maghreb and West Africa. Only a positive list of large historical accounts will continue to be served directly by Algaia in those territories.

“This agreement is a great match as both companies share the same values around the natural origin of ingredients, traceability and sustainability”, stated Fabrice Bohin, ALGAIA’s CEO, “We are looking forward to collaborating with Unipex team in 2018 to expand our presence in specialty markets such as the cosmetic or medical device industries.”